EarliPoint Health receives expanded FDA clearance for autism assessment in children up to age 8.

Read Release →

Differential Diagnosis: How Clinicians Distinguish Autism From Other Conditions

On This Page

When a parent brings a child in for a developmental evaluation, the goal is not simply to answer “autism or not.” The clinician’s role is to understand the child’s developmental profile, identify the factors contributing to the parent’s concerns, and consider other conditions that may present with overlapping behaviors.

That process is called differential diagnosis, and it’s more common than most parents expect. According to the AAP, patients with autism may also have co-occurring conditions, including intellectual disabilities, learning disabilities, ADHD, anxiety disorders, or speech and language disorders alongside their diagnosis. In many cases, those co-occurring conditions were the reason the child was referred in the first place, before anyone was certain what was driving the behavior.

Understanding the differential diagnosis process helps parents ask better questions, prepare for what an evaluation actually entails, and avoid the frustration of a misdiagnosis that leads to the wrong support.

Why Do Signs Overlap With So Many Other Conditions?

Several conditions produce behaviors that may look like autism on the surface. A child who does not respond to their name might have autism, or they might have a hearing loss, an auditory processing disorder, anxiety, or ADHD. Without a systematic process of elimination, the wrong answer is surprisingly easy to reach.

Peer-reviewed research confirms that ADHD is the most common condition co-occurring with autism, and that communication disorders are also frequently confused with it in early evaluations.

The Hearing Test Comes First

One of the first steps in any credible evaluation is a hearing test. Not responding to one’s name and limited response to voices can be indistinguishable from hearing loss without audiological testing. CDC developmental milestones flag response to name as a key 12-month marker. A hearing evaluation eliminates the most common and easily addressed explanation before any other conclusions are drawn.

Ruling Out ADHD, Anxiety, and Sensory Processing Differences

Once hearing is confirmed, specialists turn to conditions with more behavioral overlap. ADHD, for example, shares several surface features with autism: difficulty sustaining attention, impulsivity, trouble in social situations, and problems with transitions. The distinction, according to the same research, often comes down to social knowledge. Children with ADHD typically have intact social knowledge but difficulty executing it. Children with autism may lack the social knowledge itself.

Anxiety in young children can produce withdrawal, avoidance of eye contact, and resistance to new situations that overlap closely with autism presentations. Sensory processing differences add another layer of complexity. An estimated 90% of people with autism have sensory differences, but those same differences also appear in children with ADHD and in children who carry no other diagnosis at all. A child who covers their ears or reacts intensely to certain textures may be showing signs of autism, or they may not.

What a Thorough Evaluation Looks Like

A complete differential diagnosis draws on parental history, direct observation of the child, and standardized tools. Data can help identify differences that behavioral observation alone might miss or attribute to the wrong cause. The goal is to find the most accurate answer, because the right intervention depends entirely on the right diagnosis.

The Bottom Line

A child showing developmental concerns deserves a process that takes nothing for granted. Many diagnoses are often considered before a conclusion is drawn. That systematic approach is not a delay. It is the evaluation working the way it is supposed to.

Cheryl Tierney, MD, MPH

Chief Medical Officer

Developmental pediatrician, public health advocate, and Chief Medical Officer at EarliPoint Health. Cheryl blends scientific curiosity with real-world passion — as a physician, professor, and mom, she’s committed to turning early autism research into better care and support for families.

Cheryl Tierney, MD, MPH

Chief Medical Officer

Cheryl serves as EarliPoint’s Chief Medical Officer, helping advance early autism research into more accessible care and support for families.

See how EarliPoint fits seamlessly into your clinical workflow.

Jamie Pagliaro brings over two decades of leadership in autism and behavioral health to his role as President and CEO of EarliPoint. Most recently, he served as Chief Operating Officer at Rethink, a leading SaaS provider supporting individuals with autism and developmental disabilities. Under his leadership, Rethink’s behavioral health division became the company’s largest business unit, serving thousands of clinicians and driving scalable, tech-enabled care delivery.

Earlier in his career, Jamie was Executive Director of the New York Center for Autism Charter School, the first public charter school in New York State dedicated to children with autism. At EarliPoint, he leads the company’s mission to bring breakthrough science to the front lines of care—empowering providers, families, and health systems with earlier answers and better outcomes.

Jamie Pagliaro

President & Chief Executive Officer

Dr. Ami Klin is a globally recognized leader in autism research and early detection. As Director of the Marcus Autism Center and Division Chief of Autism and Developmental Disabilities at Emory University School of Medicine, he has dedicated his career to understanding how young children engage with the social world—and how subtle disruptions in attention can signal developmental differences. His pioneering work in eye-tracking science led to the development of EarliPoint™ Evaluation, the first FDA-authorized tool to objectively assess autism in children as young as 16 months.
At EarliPoint, Dr. Klin drives clinical strategy and innovation, ensuring that families and clinicians worldwide have access to timely, science-based insights that enable earlier, more personalized intervention. His career reflects a deep commitment to transforming how society supports children with autism—starting with the earliest signs.

Ami Klin, PhD

Chief Clinical Officer & Co‑Founder